Correlation Between Milestone Pharmaceuticals and Gelesis Holdings

Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Gelesis Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Gelesis Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Milestone Pharmaceuticals and Gelesis Holdings, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Gelesis Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Gelesis Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Gelesis Holdings.

Diversification Opportunities for Milestone Pharmaceuticals and Gelesis Holdings

0.0

Correlation Coefficient

Milestone Pharmaceuticals  Gelesis Holdings

Pay attention - limited upside

The 3 months correlation between Milestone and Gelesis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Gelesis Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gelesis Holdings and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Gelesis Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gelesis Holdings has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Gelesis Holdings go up and down completely randomly.

Pair Corralation between Milestone Pharmaceuticals and Gelesis Holdings

If you would invest  139.00  in Milestone Pharmaceuticals on September 2, 2024 and sell it today you would earn a total of  60.00  from holding Milestone Pharmaceuticals or generate 43.17% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Milestone Pharmaceuticals  vs.  Gelesis Holdings

Milestone Pharmaceuticals

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Milestone Pharmaceuticals are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Milestone Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Gelesis Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Gelesis Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Gelesis Holdings is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Milestone Pharmaceuticals and Gelesis Holdings

The main advantage of trading using opposite Milestone Pharmaceuticals and Gelesis Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Gelesis Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gelesis Holdings will offset losses from the drop in Gelesis Holdings' long position.

The idea behind Milestone Pharmaceuticals and Gelesis Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.